SPORTS MEDICINE
Two-year efficacy of leukocyte-rich PRP vs. corticosteroid for gluteal tendinopathy
Am J Sports Med. 2019 Apr;47(5):1130-1137. doi: 10.1177/036354651982696980 patients with grade 2-3 gluteal tendinopathy were randomized to an intratendinous injection of either leukocyte-rich platelet rich plasma or corticosteroid. Patients were initially followed-up over the first 24 weeks after injection, after which they were given the option of secondary injection with LR-PRP if they had an unsatisfactory response to the first injection. Modified Harris Hip Score were significantly greater in the LR-PRP group compared to the CS group at 12 and 24 weeks, and at 52 and 104 weeks among patients who remained in their originally allocated group. A total of 27 patients of the CS group requested secondary injection with LR-PRP. After 104 weeks, 2 patients in the LR-PRP group and 3 patients in the CS group were referred for surgical intervention.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
